Charles Barkley has lost around sixty pounds by following a mix of exercise, diet, and the mounjaro drug
Key safety observations from Phase 2 data include: Gastrointestinal side effects were the most commonly reported adverse events Dose-dependent tolerability issues were noted, particularly at higher doses, with meaningful discontinuation rates Increases in heart rate were observed, consistent with the known class effect of GLP-1 receptor agonists
Stability of Carbon Quantum Dots: A Critical Review
In contrast, oral semaglutide, even at higher doses, typically offers a bit less, with some studies reporting an average weight loss of 13.6% (source)
In November 2024, the Biden administrations CMS came out with a proposal to include the drugs under Medicare Part D, a move that the agency at the time said would recognize obesity to be a chronic disease based on changes in medical consensus, according to a fact sheet for the proposal
Clean, natural, and totally manageable